NCT04444622
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04444622
Title Immunotherapy for Third Line Metastatic Colorectal Cancer (STIMVAX)
Acronym STIMVAX
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mirror Biologics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.